Antimyoclonic properties of S2 serotonin receptor antagonists in the rat
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 25 (1) , 5-12
- https://doi.org/10.1016/0028-3908(86)90051-1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Antidepressant treatments: effects in rodents on dose‐response curves of 5‐hydroxytryptamine‐ and dopamine‐mediated behaviours and 5‐HT2 receptor number in frontal cortexBritish Journal of Pharmacology, 1983
- The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: Antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonistNeuropharmacology, 1983
- Antagonism of the effects of the hallucinogen dom and the purported 5-HT agonist quipazine by 5-HT2 antagonistsEuropean Journal of Pharmacology, 1983
- Manipulations of synaptic serotonin: Discrepancy of effects on serotonin S1 and S2 sitesLife Sciences, 1983
- Differences in the regulatory adaptation of the 5HT2 recognition sites labelled by 3H-mianserin or 3H-ketanserinNeuropharmacology, 1983
- Multiple serotonin receptors: Regional distribution and effect of raphe lesionsEuropean Journal of Pharmacology, 1981
- A BEHAVIOURAL AND BIOCHEMICAL STUDY IN RATS OF 5‐HYDROXYTRYPTAMINE RECEPTOR AGONISTS AND ANTAGONISTS, WITH OBSERVATIONS ON STRUCTURE‐ACTIVITY REQUIREMENTS FOR THE AGONISTSBritish Journal of Pharmacology, 1981
- High-affinity bindingof [3H]mianserin to rat cerebral cortexEuropean Journal of Pharmacology, 1980
- Fenfluramine-induced enhancement of confinement motor activity: An indirect 5-hydroxytryptamine-like action?Neuropharmacology, 1975
- STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHANJournal of Neurochemistry, 1971